All News #Library
Biotech
Antidepressant Drugmaker Seaport Seeks $212.4 Million In US IPO
27 Apr 2026 //
BLOOMBERG
Seaport, Hemab Prepare Ipos To Fund Depression, Clotting Drugs
13 Apr 2026 //
FIERCE BIOTECH
Seaport Therapeutics Reports Positive Phase 1 Data for GlyphAgo™
02 Apr 2026 //
PHARMIWEB
PureTech`s Seaport Publishes GlyphAllo (SPT-300) Data in Science
25 Mar 2026 //
PHARMIWEB
Seaport Therapeutics Announces Science Translational Medicine
25 Mar 2026 //
BUSINESSWIRE
Seaport Therapeutics Validates Glyph for Oral Bioavailability
08 Dec 2025 //
BUSINESSWIRE
Seaport Therapeutics To Present At Stifel Healthcare Conference
04 Nov 2025 //
BUSINESSWIRE
Seaport`s Glyph Platform Boosts Drug Absorption Via Lymphatics
12 Feb 2025 //
BUSINESSWIRE

Market Place
Sourcing Support